Biblio

Export 231 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Keyword is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
E. M. Khedr, Omeran, N., Ramadan, H. Karam- Alla, Ahmed, G. K., and Abdelwarith, A. M., Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment., J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
P. J. Lao, Handen, B. L., Betthauser, T. J., Mihaila, I., Hartley, S. L., Cohen, A. D., Tudorascu, D. L., Bulova, P. D., Lopresti, B. J., Tumuluru, R. V., Murali, D., Mathis, C. A., Barnhart, T. E., Stone, C. K., Price, J. C., Devenny, D. A., Johnson, S. C., Klunk, W. E., and Christian, B. T., Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome., J Alzheimers Dis, vol. 61, no. 2, pp. 631-644, 2018.
D. Zádori, Veres, G., Szalárdy, L., Klivenyi, P., and Vecsei, L., Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines., J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta., Neuron, vol. 78, no. 4, pp. 631-43, 2013.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood., J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood., J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood., J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
F. Wang, Xu, J., Xu, S. - J., Guo, J. - J., Wang, F., and Wang, Q. - W., Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics., J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., Anemia and Mild Cognitive Impairment in the German General Population., J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset., J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset., J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
A. Belkacemi and Ramassamy, C., Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State., J Alzheimers Dis, vol. 50, no. 4, pp. 981-98, 2016.
T. June Yoo, Anti-Inflammatory Gene Therapy Improves Spatial Memory Performance in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 3, pp. 1001-1008, 2022.
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A., APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging., Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort., J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort., J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.
A. Lladó, Froelich, L., Khandker, R. K., Roset, M., Black, C. M., Lara, N., Chekani, F., and Ambegaonkar, B. M., Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries., J Alzheimers Dis, vol. 80, no. 2, pp. 749-759, 2021.
J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C., Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline., J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C., Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline., J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
M. Siotto, Simonelli, I., Pasqualetti, P., Mariani, S., Caprara, D., Bucossi, S., Ventriglia, M., Molinario, R., Antenucci, M., Rongioletti, M., Rossini, P. Maria, and Squitti, R., Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 1181-9, 2016.
M. Siotto, Simonelli, I., Pasqualetti, P., Mariani, S., Caprara, D., Bucossi, S., Ventriglia, M., Molinario, R., Antenucci, M., Rongioletti, M., Rossini, P. Maria, and Squitti, R., Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 1181-9, 2016.
N. Kuriyama, Ozaki, E., Mizuno, T., Ihara, M., Mizuno, S., Koyama, T., Matsui, D., Watanabe, I., Akazawa, K., Takeda, K., Takada, A., Inaba, M., Yamada, S., Motoyama, K., Takeshita, W., Iwai, K., Hashiguchi, K., Kobayashi, D., Kondo, M., Tamura, A., Yamada, K., Nakagawa, M., and Watanabe, Y., Association between α-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI., J Alzheimers Dis, vol. 61, no. 1, pp. 145-155, 2018.
S. Vijayaraghavan, Darreh-Shori, T., Rongve, A., Berge, G., Sando, S. B., White, L. R., Auestad, B. H., Witoelar, A., Andreassen, O. A., Ulstein, I. D., and Aarsland, D., Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 567-76, 2016.
S. Vijayaraghavan, Darreh-Shori, T., Rongve, A., Berge, G., Sando, S. B., White, L. R., Auestad, B. H., Witoelar, A., Andreassen, O. A., Ulstein, I. D., and Aarsland, D., Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 567-76, 2016.

Pages